Jane Grogan
Head of Research, Biogen.
Companies
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 6, 2026Shares withheld for tax 584 shares at $201.18 of Biogen2
- Feb 6, 2026Exercised options 1,873 shares of Biogen2
- Feb 6, 2026Shares withheld for tax 407 shares at $201.18 of Biogen2
- Feb 6, 2026Exercised options 1,385 shares of Biogen2
- Oct 31, 2025Shares withheld for tax 337 shares at $154.27 of Biogen3
- Oct 31, 2025Exercised options 695 shares of Biogen3
- Feb 7, 2025Shares withheld for tax 443 shares at $141.35 of Biogen4
- Feb 7, 2025Exercised options 1,385 shares of Biogen4
- Nov 1, 2024Shares withheld for tax 204 shares at $173.79 of Biogen5
- Nov 1, 2024Exercised options 695 shares of Biogen5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARBiogen, Head of Research
- 2
- 3SEC EDGARForm 4 filed Nov 4, 2025
- 4SEC EDGARForm 4 filed Feb 10, 2025
- 5SEC EDGARForm 4 filed Nov 4, 2024